This video clarifies why the common advice to "eat whatever you want" during cancer treatment is misleading, emphasizing that food provides crucial signaling for your body.

We explore how nutrition impacts your immune system, shapes your gut health, and plays a vital role in reducing inflammation and cancer progression. The Mediterranean diet, highlighted by research, offers significant benefits for overall health and fighting cancer, demonstrating how foods that fight cancer can be integrated into a healthy diet.

🎯 What You’ll Learn in This Episode:
- Why food acts as immune and metabolic signaling
- How the Mediterranean diet supports cancer outcomes
- Why gut microbiome diversity matters for immunity
- The difference between ancient vs modern Mediterranean diets
- Why ultra-processed foods drive inflammation and disease
- How to build a sustainable, lifelong anti-cancer diet
- How to combine Mediterranean eating with fasting strategies
- Practical food examples that support immunity and energy

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576

“Food is your first immune therapy — if you choose it wisely.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493